Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 20,323 | 22,556 | 20,996 | 17,063 | 16,732 |
| Cost of Goods | 7,967 | 9,038 | 8,980 | 6,856 | 6,690 |
| Gross Profit | 12,356 | 13,518 | 12,016 | 10,207 | 10,042 |
| Operating Expenses | 15,639 | 15,524 | 14,440 | 14,128 | 17,119 |
| Operating Income | -2,316 | -1,968 | -1,444 | -3,065 | -6,387 |
| Other Income | 125 | 66 | 26 | 2,080 | -10 |
| Pre-tax Income | -2,191 | -1,902 | -1,418 | -985 | -6,397 |
| Net Income Continuous | -2,191 | -1,902 | -1,418 | -985 | -6,397 |
| Net Income | $-2,191 | $-1,902 | $-1,418 | $-985 | $-6,397 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.03 | -0.01 | -0.09 |
| EPS Basic Continuous Ops | -0.03 | -0.03 | -0.02 | -0.01 | -0.09 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.03 | -0.01 | -0.09 |
| EPS Diluted Continuous Ops | -0.03 | -0.03 | -0.02 | -0.01 | -0.09 |
| EBITDA(a) | $-2,045 | $-1,699 | $-1,180 | $-2,786 | $-6,125 |